Biosig Technologies Inc

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Webull's investor community can now access real-time BioSig investor communications and Q&A Webull's investor community can now access real-time BioSig investor communications and Q&A

BioSig Joins Webull Corporate Connect

Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that it is advancing the research and development of an artificial intelligence (AI) medical device platform in collaboration with technical advisory partner Reified Labs.

BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare

WESTPORT, CT / ACCESSWIRE / May 25, 2023 / Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA, last week. The platform's precision signal-capturing technology is meant to improve the speed, accuracy and precision of cardiac ablation, a widely-used surgery to treat atrial fibrillation.

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

Cleveland, OH and Westport, CT, May 19, 2023 (GLOBE NEWSWIRE) -- Researchers from Cleveland Clinic will be presenting data from three abstracts at Heart Rhythm 2023 that evaluated an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI)—a type of ablation procedure used to treat atrial fibrillation (AF)—compared to the existing standard, the Ablation Index™. Researchers used BioSig Technologies, Inc. (NASDAQ: BSGM) proprietary PURE EP™ Platform for real-time tissue-specific feedback to achieve equal lesion quality and dimension in a third of the time as conventional methods that rely on surrogate metrics.

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of new Advisory Board member Edwin Wang.

BioSig Announces New Advisory Board Member Edwin Wang

Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of Lorraine Spurge, entrepreneur and financier, to its Advisory Board.

BioSig Announces New Advisory Board Member Lorraine Spurge

Westport, CT, March 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, confirms that it does not hold any cash or maintain any accounts at Silicon Valley Bank (SVB), and has no current or prior business relationship with SVB.

BioSig Confirms No Exposure to Silicon Valley Bank

Westport, CT, Feb. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc.  (NASDAQ: BSGM) ("BioSig" or the "Company"), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, announced today that it has received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq because the bid price of the Company's common stock closed at or above $1.00 per share for a period of 10 consecutive business days, from February 6, 2023 to February 17, 2023.

BioSig Regains Compliance With All Nasdaq Listing Standards

Westport, CT, Feb. 17, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc.  (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced that the US Patent Office has issued a utility patent covering its PURE EP™ universal notch filtering technology.

BioSig Awarded US Patent Claims for its Universal Notch Filter Technology

Hillstream Biopharma

Vallon Pharmaceuticals

Why investing in penny stocks in the long term could be the right choice The post The Benefits of Investing in Penny Stocks in the Long Term  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The Benefits of Investing in Penny Stocks in the Long Term

Westport, CT, Feb. 07, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the retirement of chief financial officer Steve Chaussy following a distinguished career with the Company, and has named Steve Buhaly as his successor. Mr. Buhaly brings over 15 years of CFO experience at three public U.S. companies to his new role with BioSig.

BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy

Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced that Bellin Health System in Green Bay, Wisconsin has signed an agreement to acquire the Company's PURE EP™ System.

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology

Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference

Update: BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

Clinical abstract focuses on value of PURE EP™'s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation Clinical abstract focuses on value of PURE EP™'s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation

BioSig's PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

Westport, CT, Oct. 24, 2022 (GLOBE NEWSWIRE) --

BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology

Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress

BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022

ComSovereign Holding

Eargo

Faraday Future Intelligent Electric

Imperial Petroleum

Leafly Holdings

Minim

Penny stocks under $1 to watch before next week. The post 7 Hot Penny Stocks To Buy For Under $1 Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Hot Penny Stocks To Buy For Under $1 Before Next Week

Leading medical center in San Antonio acquires BioSig's novel digital signal processing technology for arrhythmia care Leading medical center in San Antonio acquires BioSig's novel digital signal processing technology for arrhythmia care

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

Penny stocks under $1 to watch before next week. The post 4 Hot Penny Stocks To Buy For Under $1 Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Hot Penny Stocks To Buy For Under $1 Before Next Week

Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic's Global EP Summit 2022, a world-class leadership symposium Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic's Global EP Summit 2022, a world-class leadership symposium

BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

Bluejay Diagnostics

Sharps Technology Inc

The Dow Jones closed higher by more than 400 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

OppFi

Williams Industrial Services Group Inc.

The Dow Jones closed lower by more than 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

(BSGM), (OPFI) – 3 Stocks Under $3 Insiders Are Buying

loanDepot

Reliance Global Group

U.S. stocks recorded losses for the fourth straight session on Wednesday. Investors, meanwhile, focused on some notable insider trades.

(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively Buying

Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that it has expanded its marketing and sales teams to scale and support the national commercial rollout of its PURE EP™ System.

BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth

News for Biosig Technologies Inc Stock (BSGM)